UNSPSC 85891413: High dose rate (hdr) brachytherapy of bone marrow using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of bone marrow using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D7109CZ

UNSPSC 85891413 High dose rate (HDR) brachytherapy of bone marrow using californium 252 (Cf-252) is a Commodity code with no recent state and local procurement activity matching its nominal scope. The single recent opportunity tagged under this code—a County of Santa Clara Health System RFQ for temporary health professional staffing services across ancillary clinical categories (Audiology, Cardiology, Diagnostic Imaging, Gastroenterology, Health Services Assistant, Medical Social Worker, Ophthalmology, Orthopedic, Patient Transporter, Respiratory Care, Sterile Processing, Surgical/Operating Room, and Therapy Services)—does not align with specialized cancer treatment modalities and appears to be a classification mismatch rather than genuine procurement under the code's intended scope.

The County of Santa Clara Health System issued RFSQHHSFY270052 as a multiple-award qualification vehicle with no guaranteed work volume, with proposals due October 7, 2026. The Health System explicitly excluded nursing, physician, and other non-clinical staffing from the solicitation and reserved the right to maintain the Qualified List for five years. Given the absence of substantive recent opportunities aligned with the code's actual commodity definition, this code presents minimal near-term pursuit opportunity for firms targeting state and local procurement.